Skip to content
healthcare.dev

Hyoscyamine ER

NDC 51525-0115, hyoscyamine sulfate, tablet, extended release, from Mylan Pharmaceuticals Inc..

Product NDC
51525-0115
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51525-0115 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYOSCYAMINE SULFATE.375 mg/1
Package NDCNDC-11Package
51525-0115-151525011501100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51525-0115-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5bbce8c0-a9c9-45b9-8457-1542bd3d9449

Use it

Look up 51525-0115 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51525-0115 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51525-0115. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.